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2416 The Journal of Craniofacial Surgery  Volume 30,Abstract: Integra is a dermal regeneration template used in the
reconstruction of burns, traumatic injuries, or excision lesions in
patients who present particular risk factors for traditional surgical
procedures. A multidisciplinary advisory board of expert dermatol-
ogists and plastic surgeons have discussed the use of Integra in the
reconstruction of scalp defects after tumor excision, focusing on the
evidence derived from literature and on their experience in the
treatment of approximately 400 patients. In this position paper, the
authors summarize the main evidence discussed during the board,
and the common practice guidelines proposed by the experts. The
use of Integra is recommended in elderly patients with multiple
comorbidities who have a higher risk for potential complications in
traditional surgery; these patients may in fact benefit from a lower
anesthetic risk, a less complicated postsurgical care and limited
morbidity at the donor site obtained with the dermal template.
Integra should also be used in the reconstruction of large and
complex wounds and in case of bone exposure, as it helps to
overcome the challenges related to wound healing in difficult areas.
Notably, Integra has proven to be effective in patients who have
undergone previous surgical procedures or adjuvant radiation ther-
apy, in which previous incisions, scarring and radiation damages
may hamper the effectiveness of traditional procedures. Finally,
Integra is recommended in patients with recurrent and aggressive
tumors who need closer tumor surveillance, as it gives easy access
to the tumor site for oncologic follow-up examination.Key Words: Dermal matrix, Integra, scalp reconstructive surgery,
tumor excision
(J Craniofac Surg 2019;30: 2416–2420)
he reconstruction of scalp defects after tumor resection repre-T sents a difficult surgical challenge, especially considering the
mounting incidence of skin cancer among elderly patients.1 Stan-
dard reconstructive techniques follow a step-wise approach that
incorporate principles of the reconstructive ladder. Free tissue
transfers, local flaps, or skin grafts are usually used in cases of
smaller-medium wounds, while larger or infected or previously
irradiated wounds can be treated by free tissue transfer.2,3 Each of
these options has advantages and limitations, and is chosen based on
anatomical characteristics of the lesion, as size, depth, and quality
of regional tissue, and patient-related factors, including physical
and mental health, comorbidities, and patient preferences.4
Traditional surgical approaches have a limited application in
elderly patients, which may present additional risk factors due to
comorbidities (eg, diabetes and cardiac disorders), concomitant
medications, problems at donor site, and anesthetic tolerance.5
Moreover, the peculiar anatomy, mobility, and poor vascularization
of the scalp poses additional challenges in surgical reconstruction,
especially in cases of wide local excision leading to bone exposure.
In fact, the exposure of the skull bone leads to slow formation of
granulation tissue and wound healing by secondary intention,
increasing the risk of flap necrosis, especially in older patients.6
Lastly, cancer patients may present additional complications, such
as the extent of resection, especially in advanced stages, need for
preservation of original surgical margin orientation, possibility of
tumor recurrence, and requirement for adjuvant radiation therapy.3,7
Patients at higher risk for traditionally reconstructive procedures
may benefit from the use of biologically engineered materials, also
called dermal matrix, that help generate a new dermis, offering
major improvements in the coverage of complex and larger
defects.8 Integra is a dermal regeneration template composed of
a layer of bovine collagen crosslinked with glycosaminoglycan
covered by a silastic membrane. The silicone layer temporary closes
the wound to ward off infections and control fluid and heat loss,
while the collagen matrix promotes infiltration of host cells, which
eventually form a neodermis in 3–6 weeks. The generation of the
new dermis provides a reliable recipient bed for split-thickness skin
grafting, which replaces the silicone layer.8–10
Integra has been widely used in reconstructive procedures to treat
burns, ulcers, traumatic injuries, or excision lesions all over the body,
leading to long-term engraftment and excellent cosmetic and func-
tional results.11–13 Multiple retrospective studies and case reports
have also reported the successful use of Integra in the reconstruction
of scalp defects after excision of different types of tumors.6,14–16
However, common guidelines on the use of Integra after tumor
excision on the scalp is still lacking and variance in patients and
defect characteristics leads to a highly individualized treatment.on of this article is prohibited.
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The Journal of Craniofacial Surgery  Volume 30, Number 8, November/December 2019 Integra in Scalp ReconstructionA multidisciplinary team of expert dermatologists and plastic
surgeons has recently discussed the use of Integra in the surgical
reconstruction of scalp defects after tumor excision, with the aim to
define some common practice guidelines. This position paper
summarizes the main findings of the discussion and the final
recommendations provided by the experts.
INTEGRA IN SCALP RECONSTRUCTION AFTER
TUMOR EXCISION: EVIDENCE FROM THE
LITERATURE
Various retrospective studies and case reports have reported the
efficacy and safety of Integra in the reconstruction of scalp defects
after tumor excision.17 A detailed description of these studies goes
beyond the scope of this position paper and can be found in 2 recent
papers published by Johnson et al and by Watts et al,18 who
conducted very interesting systematic reviews on the use of Integra
in the reconstruction of complex full thickness scalp defects.14
Notably, while these reviews primarily focus on the main evidence
available in literature, in this position paper we aimed at discussing
more in depth the positioning of Integra in clinical practice,
reporting the experience and recommendations of clinical experts.
The most important retrospective studies and case reports dis-
cussed during the multidisciplinary board are summarized in Table 1
(Supplemental Digital Content, http://links.lww.com/SCS/A590).
Elderly Patients With Comorbidities
Integra has been extensively used in the reconstruction of scalp
defects in elderly patients presenting with multiple comorbidities,
for whom traditional surgical procedures are deemed inappropriate.
In 2011, Corradino et al reported the successful use of Integra in
eight elderly patients (mean age: 81.5 years) with scalp malignant
tumors, for which a traditional surgical reconstruction was deemed
not tolerable. Patients underwent a 2-step procedure under local
anesthesia, initially consisting of tumor removal and Integra posi-
tioning, and followed, 3 weeks later, by the removal of Integra
silicone layer and covering of the defect with a split-thickness graft.
The procedures were successful in all the patients with no com-
plications and led to satisfactory cosmetic and functional results;
moreover, in 2 cases, Integra allowed the detection of an early
tumor recurrence 2 months after the first operation.19
Positive results in older patients (mean age: 85.5 years) were
also reported in a small series of 4 subjects treated at the University
Hospital Coventry and Warwickshire (UK) for squamous cell
carcinoma (SCC; n¼ 2), basal cellular carcinoma (BCC; n¼ 1),
and angiosarcoma (n¼ 1) of the scalp. Of note, the series comprises
a 93-year-old man with SCC of the scalp, who suffered from
multiple comorbidities including diabetes, hypertension, and
chronic renal failure; he reported a 100% graft take with Integra
and no complications.20
In 2015, another retrospective analysis was published on 20
elderly patients with multiple comorbidities and extended defects of
the scalp, treated with Integra. Mean age was 80 years and the most
common tumor type was BCC (16 cases), followed by SCC (4
cases). Patients also had multiple comorbidities, including arterial
hypertension, coronary heart disease, atrial fibrillation, use of
antiplatelet drugs, chronic renal failure, diabetes mellitus type II,
smoking habits, and chronic lymphocytic leukemia. Integra recon-
struction was successful with 100% engraftment rate and only
minor complications occurred in 2 cases. Of note, while in most
of the studies the Integra-based reconstruction is performed in a 2-
step procedure, in this study, a single-step procedure was chosen
and the neodermis formed after Integra positioning was not covered
with skin graft after silicon removal. The procedure was successful,Copyright © 2019 Mutaz B. Habal, MD. Unautho
# 2019 Mutaz B. Habal, MDwith healing by secondary intention occurring within 35–50 days,
and with the additional advantage of avoiding a 2nd surgical
intervention.17
Complex Wounds and Bone Exposure
Several studies have reported the use of Integra in reconstruction
of complex wounds located in the scalp, an anatomical site that
poses additional challenges in surgical reconstructive procedures.
In 2005, Wilensky et al conducted a retrospective study on 23
elderly patients treated with Integra for the reconstruction of
complex full-thickness defects of the scalp, with exposed cranium.
The majority of the patients (n¼ 13) were diagnosed with mela-
noma either as primary diagnosis or after recurrence; additional
tumor types included SCC (n¼ 5), angiosarcoma (n¼ 2), BCC
(n¼ 1), spindle cell carcinoma (n¼ 1), and malignant pilar tumor
(n¼ 1). Traditional surgical procedures were deemed unsuitable
due to the complexity of the defect, higher risk of tumor spreading
with immediate or transposition flaps, and additional risks of
general anesthesia for elderly patients. The authors opted for radical
resection with generous margins, and the average defect size
requiring reconstruction was 51 cm2 (range: 9–169 cm2). Integra
led to successful engraftment in 100% of the patients with minimal
morbidity and no mortality. The only complications reported by the
authors were infection, which was observed in 21.7% of the
patients, and delayed healing reported in 5 patients.15
In 2009, Koenen et al reported their experience on 13 patients
with cutaneous malignancies of the scalp treated with Integra.
Patients presented with multiple types of cutaneous tumors includ-
ing rare and aggressive malignancies. In consideration of the safety
margins recommended for the respective type of tumor (ranging
from 1 to 3 cm) the authors opted for wide local resection with
partial removal of the outer table of the skull to reduce the risk of
local recurrence. Within a period of 29 days after the first surgery,
all the patients reported sufficient granulation tissue formation and
the defect was subsequently covered with an ultrathin graft, which
healed within 9–13 days. Only 1 patient reported infection of the
template, while no cases of seroma, necrosis, or hematoma were
reported.6
Positive results with the use of Integra were observed also by
Chalmers et al who studied the reconstruction of complex surgical
defects in 14 patients with excision up to the bone or tendon. In this
series, 6 patients were diagnosed with scalp malignancies and were
classified as complex cases due to significant comorbidities, large
areas of exposed bone, previous surgery, and/or radiotherapy.
Patients were diagnosed with SCC (n¼ 4), metastatic melanoma
(MM; n¼ 1), and sarcoma (n¼ 1), and the mean defect area after
tumor excision was 163 cm2 (range: 49–289 cm2). Integra was
efficient in the reconstruction of these complex and poorly vascu-
larized wounds, graft take tanged from 50% to 100% and registered
complications included hematoma (1 case) and delayed healing (1
case).12
Of note, the importance of extensive resection of scalp tumors is
suggested by a comparative analysis performed in 2012, based on
which subperiosteal resection is recommended in patients with
node-negative primary scalp melanoma. The authors of the study
compared the risk of in-transit/satellite recurrence among 48
patients with scalp melanoma undergoing either subperiosteal (at
the level of calvarium, 23 patients) resection with Integra-based
reconstruction or subgaleal resection (resection of skin, subcutane-
ous tissue, and galea, 45 patients) followed by skin graft. The study
shows that, although the 2 procedures were similar in terms of
engraftment take (97% versus 96%), the recurrence rate was
remarkably higher among patients in the subgaleal resection group
compared to those in which the resection of the melanoma includedrized reproduction of this article is prohibited.
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of complete excision of scalp tumors.21
Interestingly, Integra has proven to be safe and effective also in
the reconstruction of extremely large scalp defects. Fung et al
reported the successful use of Integra in a 69-year-old patient with
a history of nonmelanoma scalp tumor who underwent a wide
excision of an area of 256 cm2 including the pericranium. The 2-
stage use of Integra, followed by SSG was successful, and after
14 months the patient was fully healed with no recurrence.22
Similarly, Cunningham et al obtained successful results with Inte-
gra followed by negative pressure wound therapy (NPWT) in a 63-
year-old man with numerous superficial and invasive SCC of the
scalp that required excision of a total area of 400 cm2.23
PREVIOUS SURGERY, RADIATION THERAPY,
AND TUMOR RECURRENCE
Integra has been used for the reconstruction of scalp defects in
patients who had previous surgery, for which the anesthetic risk is
higher, and in those suffering from aggressive/recurrent tumors that
might need pre- or postsurgery radiation therapy.
In 2005, Komorowska-Timek et al reported their experience on a
small population of 7 elderly patients undergoing partial- or full-
thickness scalp reconstruction with Integra after removal of a scalp
tumor. In detail, 4 patients were diagnosed with BCC, 2 patients with
MM, and 1 patient with glioblastoma. Patients presented multiple
risk factors for traditional surgical procedures including older age,
diagnosis of recurrent malignant tumors (5 cases), preoperative
radiation of the scalp (2 cases), and previously failed reconstruction,
including local flaps (n¼ 1), split-thickness skin graft (n¼ 3), and
failed latissimus dorsi (n¼ 1). The application of Integra was
successful in all the patients, with 100% graft and formation of a
well-vascularized neodermis before skin grafting. No infection or
other complications were noted in this series and patients benefited
from satisfactory cosmetic and functional results.24
In 2007, Tufaro et al analyzed the use of Integra in 17 patients
with soft-tissue tumors located in different anatomical location,
including 7 patients with scalp tumors such as MM (n¼ 3), BCC þ
SCC (n¼ 1), dermatofibrosarcoma (n¼ 1), and others (n¼ 2).
Patients presented with complex defects that needed excision
extending to the bone/periosteum, had a history of previous surgery
(n¼ 4) or had received perioperative chemotherapy (n¼ 1). The
authors reported excellent cosmetic and functional results, and less
donor-site morbidity. Of note, Integra led to successful reconstruc-
tion also in patients treated with pre- and postoperative irradiation at
the surgical site, thus suggesting the efficacy of this surgical
procedure regardless of the negative effects of radiation therapy
on the skin.25
Khan et al conducted one of the largest retrospective reviews of
30 cases of full-thickness scalp reconstruction using Integra. Most
of the patients were diagnosed with MM (n¼ 15), followed by SCC
(n¼ 6), BCC (n¼ 3), basosquamous carcinoma (n¼ 2), and der-
matofibrosarcoma protuberans (n¼ 2). All the patients included in
the series had undergone previous oncology surgery with a wide
excision, including 15 cases of primary closure, 11 reconstructions
with local flaps, and 4 skin grafts; moreover, nine patients had had
neoadjuvant radiotherapy and 3 patients received postoperative
radiotherapy. Overall patients reported a 100% graft success, with
only 2 minor complications being infection and seroma in 1 case
each. Two patients suffered from recurrence while 28 had close
margins and aggressive tumors that required further excision and
soft-tissue cover, thus underlining the advantages of Integra in
terms of tumor surveillance. Moreover, radiotherapy had no adverse
effect on Integra take and none of the patients reported radiother-
apy-related wound breakdown.16Copyright © 2019 Mutaz B. Habal, MD. Unautho
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an aggressive tumor has been also reported in a case report
published in 2003. Gonyon and Zenn described the case of a 62-
year-old man with multiple comorbidities including previous sur-
gery, diagnosed with a large and recurrent SCC of the scalp that
required total scalp irradiation. The patient also had an extremely
large defect and required the excision of a 400-cm2 area of almost
the entire left scalp, with exposed pericranium and bone. Integra-
based reconstruction was successful leading to the creation of an
excellent vascularized bed for skin grafting despite heavy radiation
damage in the recipient scalp.26
RECOMMENDATION FOR INTEGRA USE IN
SCALP RECONSTRUCTION
Overall, the authors of this study have treated 395 patients with
Integra, with an overall success rate of 90% and a low number of
complications (the most common being infection, 6%). A descrip-
tion of the patients we treated, without any further statistical
evaluation, is reported in Table 2 (Supplemental Digital Content,
http://links.lww.com/SCS/A590).
Patients
The use of Integra is recommended in elderly patients with
comorbidities that constitute an anesthetic risk (ASA) 3. Older
patients have a higher risk of potential complications associated
with general anesthesia and postoperative recovery; moreover, they
usually suffer from concomitant conditions that make them unfit to
undergo major reconstructive procedures, such as free tissue trans-
fer or regional flaps. Reconstruction with Integra is recommended
in these patients as it can be done with local anesthesia and usually
requires shorter recovery time. Moreover, Integra requires a less
complicated care in the postsurgical phase, and can be followed by
thin skin graft, thus reducing the morbidity at the donor site.
Tumor Characteristics
In terms of lesion size, Integra is useful in case of cancer or
precancerous lesions with a diameter4 cm localized to the scalp to
avoid local flaps or skin grafts. Notably, Integra has reported
successful results in the reconstruction of defects up to 400 cm2,
and the reconstruction of larger scalp wounds does not seem to be
associated with significantly increased complication rates.23,26
Integra is also recommended in case of full-thickness resection
down to the bone surface with the sacrifice of the periosteum. The
exposed skull bone is characterized by slow formation of granula-
tion tissue and reduced wound healing by secondary intention,
increasing the risk of flap necrosis with traditional procedures.
Literature evidence suggests that Integra provides higher quality
coverage over wounds with exposed bone, and is efficient in
stimulating the creation of a new vascularized dermis.6,12,15,25
Notably, the panel of authors has reported the use of the dermal
substitute directly on periosteum (when present), on well-vascular-
ized exposed bone, and also on non-well-vascularized exposed bone
(especially in case of elderly patients or postradiation therapy),
which was drilled prior to the positioning of the dermal substitute in
order to obtain an efficient vascularized bed.
In terms of tumor types, Integra has shown successful results
after excision of SCC, BCC, and MM6,12,15,17,20,24,27–29 and, as
described in some reports dermatofibrosarcoma protuberans.16,25
Of note, BCCs are the most common malignancies observed in
older patient and require smaller surrounding margins (<5mm);
conversely, in case of more aggressive tumors such as invasive SCC
and MM, it is recommended to include wider margins (>5mm).
Additional safety margins (2–4 cm) may be considered to betterrized reproduction of this article is prohibited.
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subperiosteal resection is recommended in patients with node-nega-
tive primary scalp melanoma.6,21 In this regard, as previously
reported, Integra is effective in the reconstruction of both large
defects and deep lesions with exposed bones, thus enabling a
complete resection that reduces the risk of tumor recurrence.6,12,15,25
The use of Integra presents additional advantages in patients
with recurrent tumors, as it gives easy access to the tumor site for
oncologic follow-up examinations, facilitating the detection of
early recurrences and allowing the resection of residual tumors
before the final reconstruction step.12,16,19,24
Moreover, the possibility to reconstruct the scalp with dermal
substitute allows for a more aggressive tumor excision with higher
rate of oncologic safety.21 Traditional reconstructive procedures,
such as transposition flaps, might be oncologically unsound in
patients with recurrent and aggressive tumors, as they can cause
tumor spread beyond the site of the original resection, and they
might cover residual or recurring tumors. Oncologic safety can be
achieved by a radical excision, demonstrated by clear tumor
margins obtained in the histopathology examination. When tumor
margins are not clinically well defined, a 2-step procedure might be
necessary, with completed tumor excision and delayed definitive
reconstruction after the confirmation of histopathology clear mar-
gin. In these cases, the dermal substitute can be positioned at the
time of tumor excision, as it represents the only surgical option
before the histopathology report.
Integra can also be used in patients requiring pre- or postsurgery
radiotherapy. Radiation therapy is a known risk factor for wound
healing, as it results in reduced blood flow and damage to host
fibroblast, eventually limiting the healing potential of the tissue, and
increasing the complication rates of traditional surgical procedures.
Literature data show that Integra is efficient in creating a vascular-
ized bed also in heavily irradiated scalp.26 Moreover, postoperative
irradiation after Integra-based reconstruction appears to be well
tolerated and although some of the patients may experience mild
acute radiodermatitis and/or radionecrosis; the outcomes are overall
good, with engraftment rates above 95%.6,12,16,21,24,27,29
Finally, Integra is recommended in patients who underwent
previous surgical procedures, in which previous incisions and
scarring make traditional surgery approaches difficult and unpre-
dictable.16,24,25
Steps and Dressings
Although a few case reports and studies have reported the
successful use of Integra in healing by secondary intention, the
2-step procedure remains to be the standard approach to Integra-
based reconstruction. Secondary healing seems to be sufficient in
some cases and has the advantage of avoiding a 2nd procedure for
the patient; however, it requires longer time to heal, with mean time
to bone epithelization of 13 weeks.30,31 In addition, the single-step
procedure is not feasible for large full-thickness scalp wounds,
where bone is devoid of the periosteum.25 The 2-step procedure is
therefore recommended as standard approach, as it provides effec-
tive and durable results for all defect size.
In terms of dressing the most commonly used options were
bolstered dressing,15,17,19,22,24,26,32,33 silver-impregnated dress-
ing6,16,25 and NPWT,12,23,28,34,35 which is effective in reducing
shearing forces across the surface of the dermal matrix by acting as
a splint and forces the material on to the wound bed. The authors
recommendation is to perform the dressing with nonadherent
wound contact layer (eg, fatty gauze) on top and apply Betadine
gel (Braunol; B. Braun, Milan, Italy), silver sulfadiazine or other
silver dressings to the edge, followed by traditional compressive
over the bandage. In selected cases, an NPWT dressing can be
used depending upon the site and size of the wound.36 The onlyCopyright © 2019 Mutaz B. Habal, MD. Unautho
# 2019 Mutaz B. Habal, MDcomplications reported by the experts on the use of NPWT are
detachment of the dermal substitute from the wound bed and
development of infection.
CONCLUSION
In conclusion, Integra is a safe and effective option in the recon-
struction of scalp defects after the excision of multiple types of
tumor, including SCC, BCC, MM, and dermatofibrosarcoma pro-
tuberans. The use of Integra is recommended particularly in elderly
patients with multiple comorbidities, patients with large and com-
plex wounds that lead to bone exposure, and patients with recurrent
and aggressive tumors who have undergone previous surgical
procedure, and may need adjuvant radiation therapy or for whom
a close tumor surveillance is recommended.
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